• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全血细胞计数反映巨细胞动脉炎的疾病状态:一项对中国患者的回顾性研究。

Complete blood count reflecting the disease status of giant cell arteritis: A retrospective study of Chinese patients.

作者信息

Yin Yue, Zhang Yun, Wang Dongmei, Han Xinxin, Chu Xiaotian, Shen Min, Zeng Xuejun

机构信息

Department of General Practice (General Internal Medicine), Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Science (CAMS) and Peking Union Medical College (PUMC), Beijing.

Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou.

出版信息

Medicine (Baltimore). 2020 Sep 25;99(39):e22406. doi: 10.1097/MD.0000000000022406.

DOI:10.1097/MD.0000000000022406
PMID:32991468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7523864/
Abstract

Giant cell arteritis (GCA) is the most common vasculitis in elderly, with ischemic and constitutional symptoms caused by vascular involvement and systemic inflammation. Early initiation of therapy results in prompt remission, while patients may still experience flares or severe complications during glucocorticoid tapering. This study was to identify the characteristics of Chinese GCA patients with different prognosis.Ninety-one patients diagnosed with GCA in Peking Union Medical College Hospital in the last 20 years were followed up. Those who were lost to follow up or were followed up for less than 1 year were excluded. According to the prognosis, patients were divided into the group of favourable prognosis (patients who sustained disease remission for over 1 year) and unfavorable prognosis (patients who had relapses or severe complications). Clinical data at disease onset and after treatment were collected and analysed between the 2 groups.Thirty-seven patients with favourable prognosis and 40 patients with unfavourable prognosis were admitted into the study. Fever as an onset symptom was less common in favourable group (P=.016). As for presentations of GCA, fever, tenderness and abnormal pulsation of temporal artery and jaw claudication were less frequently observed in patients with favourable prognosis (P=.029, .049, .043, respectively). At onset, medium-size arteries were affected more in unfavorable prognosis group (P = .048), and involvement of branches below the aortic arch were more common in favorable prognosis group (P = .034). Erythrocyte sedimentation rate in group of favourable prognosis were significantly lower after treatment (P = .041). Compared with healthy subjects, GCA patients had increased monocytes and decreased lymphocytes at disease onset (P < .01). Monocyte counts were higher in patients with favourable prognosis at disease onset (P = .043), while no significant differences were seen between the 2 groups after treatment. Lymphocyte counts were lower in patients with unfavourable prognosis (P = .014) after treatment.Complete blood count may reflect the disease status of GCA. Little change in monocyte during treatment and lower lymphocytes after treatment may serve as potential predictors of unfavourable clinical prognosis.

摘要

巨细胞动脉炎(GCA)是老年人中最常见的血管炎,因血管受累和全身炎症导致缺血性及全身性症状。早期开始治疗可迅速缓解,但患者在糖皮质激素减量过程中仍可能出现病情复发或严重并发症。本研究旨在确定不同预后的中国GCA患者的特征。

对过去20年在北京协和医院诊断为GCA的91例患者进行随访。排除失访或随访时间不足1年的患者。根据预后情况,将患者分为预后良好组(疾病缓解持续超过1年的患者)和预后不良组(有复发或严重并发症的患者)。收集并分析两组患者发病时及治疗后的临床资料。

37例预后良好的患者和40例预后不良的患者纳入研究。发热作为首发症状在预后良好组中较少见(P = 0.016)。至于GCA的表现,发热、颞动脉压痛及搏动异常和颌部间歇性运动障碍在预后良好的患者中较少见(分别为P = 0.029、0.049、0.043)。发病时,预后不良组中、大动脉受累更多(P = = 0.048),而主动脉弓以下分支受累在预后良好组中更常见(P = 0.034)。治疗后,预后良好组的红细胞沉降率显著降低(P = 0.041)。与健康受试者相比,GCA患者发病时单核细胞增多而淋巴细胞减少(P < < 0.01)。发病时,预后良好的患者单核细胞计数较高(P = 0.043),但治疗后两组间无显著差异。治疗后,预后不良的患者淋巴细胞计数较低(P = 0.014)。

全血细胞计数可反映GCA的疾病状态。治疗期间单核细胞变化不大及治疗后淋巴细胞减少可能是不良临床预后的潜在预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d3/7523864/8fecd76a8161/medi-99-e22406-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d3/7523864/617a67f5f18d/medi-99-e22406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d3/7523864/5658cdedd75f/medi-99-e22406-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d3/7523864/8fecd76a8161/medi-99-e22406-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d3/7523864/617a67f5f18d/medi-99-e22406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d3/7523864/5658cdedd75f/medi-99-e22406-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d3/7523864/8fecd76a8161/medi-99-e22406-g005.jpg

相似文献

1
Complete blood count reflecting the disease status of giant cell arteritis: A retrospective study of Chinese patients.全血细胞计数反映巨细胞动脉炎的疾病状态:一项对中国患者的回顾性研究。
Medicine (Baltimore). 2020 Sep 25;99(39):e22406. doi: 10.1097/MD.0000000000022406.
2
Comparisons of clinical manifestations and prognosis between giant cell arteritis patients with or without sensorineural hearing loss: A retrospective study of Chinese patients.伴有或不伴有感音神经性听力损失的巨细胞动脉炎患者的临床表现及预后比较:一项针对中国患者的回顾性研究
Medicine (Baltimore). 2019 Apr;98(17):e15286. doi: 10.1097/MD.0000000000015286.
3
A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated With Severe Ischemic Manifestations.中国巨细胞动脉炎(GCA)患者的回顾性研究:临床特征及与严重缺血表现相关的因素
Medicine (Baltimore). 2016 Mar;95(13):e3213. doi: 10.1097/MD.0000000000003213.
4
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control study.红细胞沉降率(ESR)和C反应蛋白(CRP)水平较低的新发巨细胞动脉炎与其他形式的疾病具有相似的缺血风险,但预后良好:一项病例对照研究
Rheumatol Int. 2023 Jul;43(7):1323-1331. doi: 10.1007/s00296-023-05299-1. Epub 2023 Apr 7.
5
Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.转诊接受颞动脉活检的患者最终诊断为巨细胞动脉炎的基线临床预测因素。
Clin Rheumatol. 2016 Jul;35(7):1817-22. doi: 10.1007/s10067-016-3221-1. Epub 2016 Mar 1.
6
Temporal Artery Biopsy in the Workup of Giant Cell Arteritis: Diagnostic Considerations in a Veterans Administration Cohort.颞动脉活检在巨细胞动脉炎中的应用:退伍军人管理局队列中的诊断考虑因素。
J Neuroophthalmol. 2020 Dec;40(4):450-456. doi: 10.1097/WNO.0000000000001040.
7
Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.白细胞动力学揭示巨细胞动脉炎和风湿性多肌痛中持续的髓系优势。
Front Immunol. 2019 Aug 22;10:1981. doi: 10.3389/fimmu.2019.01981. eCollection 2019.
8
Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients.巨细胞动脉炎相关的上下肢血管炎的长期随访:36例病例系列
Medicine (Baltimore). 2011 Jan;90(1):40-51. doi: 10.1097/MD.0b013e318206af16.
9
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.巨细胞动脉炎合并抗中性粒细胞胞质抗体相关性血管炎:一项病例对照研究。
Arthritis Rheumatol. 2021 Feb;73(2):286-294. doi: 10.1002/art.41527. Epub 2020 Dec 21.
10
Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.血小板增多症在巨细胞动脉炎诊断及动脉炎性与非动脉炎性前部缺血性视神经病变鉴别中的作用。
Eur J Ophthalmol. 2004 May-Jun;14(3):245-57. doi: 10.1177/112067210401400310.

引用本文的文献

1
Diagnostic Dilemmas in Giant Cell Arteritis: Overcoming Anchoring Bias.巨细胞动脉炎的诊断困境:克服锚定偏差
Case Rep Rheumatol. 2025 Jul 21;2025:6632374. doi: 10.1155/crrh/6632374. eCollection 2025.
2
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force.评估巨细胞动脉炎的治疗结局和疾病活动变化:一项系统文献回顾,代表巨细胞动脉炎 EULAR-ACR 反应标准工作组为 EULAR-ACR 反应标准的制定提供信息。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003233.
3

本文引用的文献

1
Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.白细胞动力学揭示巨细胞动脉炎和风湿性多肌痛中持续的髓系优势。
Front Immunol. 2019 Aug 22;10:1981. doi: 10.3389/fimmu.2019.01981. eCollection 2019.
2
Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?评估心血管疾病中的全血细胞计数参数:预后的早期指标?
Exp Mol Pathol. 2019 Oct;110:104267. doi: 10.1016/j.yexmp.2019.104267. Epub 2019 Jun 11.
3
[Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, and Analysis.
大动脉炎患者的心血管风险与舒张功能障碍及血管壁炎症细胞浸润直接相关:一项临床研究与分析。
Front Med (Lausanne). 2022 May 16;9:863150. doi: 10.3389/fmed.2022.863150. eCollection 2022.
[术前血清肿瘤标志物与外周血血常规指标联合检测对结直肠癌患者的预后价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Dec 25;21(12):1421-1426.
4
Predicting mortality in subarachnoid haemorrhage based on first-week routine blood tests.基于首周常规血液检测预测蛛网膜下腔出血患者的死亡率
J Clin Neurosci. 2018 Dec;58:100-107. doi: 10.1016/j.jocn.2018.09.016. Epub 2018 Oct 9.
5
Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.巨细胞动脉炎和风湿性多肌痛:当前的挑战和机遇。
Nat Rev Rheumatol. 2017 Oct;13(10):578-592. doi: 10.1038/nrrheum.2017.142. Epub 2017 Sep 14.
6
Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis.单核细胞亚群在巨细胞动脉炎免疫病理学中的作用。
Sci Rep. 2017 Jul 26;7(1):6553. doi: 10.1038/s41598-017-06826-4.
7
Risk factors for severe cranial ischaemic events in patients with giant cell arteritis.巨细胞动脉炎患者发生严重颅脑缺血事件的危险因素。
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):88-93. Epub 2017 Apr 19.
8
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.巨细胞动脉炎和风湿性多肌痛的谱系:重新审视疾病概念
Rheumatology (Oxford). 2017 Apr 1;56(4):506-515. doi: 10.1093/rheumatology/kew273.
9
Giant cell arteritis.巨细胞动脉炎。
Best Pract Res Clin Rheumatol. 2016 Feb;30(1):169-88. doi: 10.1016/j.berh.2016.05.001. Epub 2016 Jun 20.
10
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.巨细胞动脉炎与风湿性多肌痛:系统评价。
JAMA. 2016 Jun 14;315(22):2442-58. doi: 10.1001/jama.2016.5444.